Non-Sponsored Symposium (NSS)

NSS1
Joint IOF and CABS Symposium - Cancer and Bone
Chairpersons: P. Hadji, R. Coleman
Cancer treatment induced osteoporosis - really important? - P. Hadji
Influence of adj. bisphosphonates and denosumab on breast cancer outcome. - R. Coleman
Surgical treatment of bone metastasis – Update 2021 - A.A. Kurth


NSS2
The Asia Pacific Consortium on Osteoporosis (APCO) NSS Paving the Way Forward for Harmonization of Osteoporosis Guidelines - the Pan Asia and Oceania FRAMEWORK of the Asia Pacific Consortium on Osteoporosis (APCO)
Chairpersons: Cyrus Cooper, Philippe Halbout
The Asia Pacific Consortium on Osteoporosis – A brief introduction - Manju Chandran
5IQ: A novel analysis of extant guidelines - Paul Mitchell
The Delphi Process: Developing consensus amongst experts from 19 countries and regions - Manju Chandran
Embedding the Framework in the Asia Pacific - Greg Lyubomirsky and Ms Thalia Georgiou
Conclusion


NSS3
Breast Cancer and Osteoporosis
Chairperson: Yannis Dionyssiotis
Breast cancer and osteoporosis - Lambros Athanassiou
Estrogen receptor antagonists and osteoporosis - Yannis Dionyssiotis
Pathophysiology of osteoporosis in the context of estrogen receptor antagonist treatment - Panagiotis Athanassiou
Management of osteoporosis in breast cancer patients - Ifigenia Kostoglou-Athanassiou


NSS4
Exosomes to diagnose and treat musculoskeletal diseases: An update
Chairperson: Gustavo Duque
Extracellular vesicles in musculoskeletal diseases - Mark W. Hamrick
The role of extracellular vesicles in the pathophysiology and treatment of osteosarcopenia - Gustavo Duque
Therapeutic applications of MSC derived extracellular vesicles in osteoarthritis - Susanne Grässel


NSS6
SARC-F for sarcopenia: high potential for new applications
Chairperson: John Morley
The comparison of SARC-F with other screening tools for sarcopenia. - Karolina Piotrowicz
SARC-F Questionnaire Detects Frailty in Older Adults - Serdar Ozkok
Ability of SARC-F to Find Probable Sarcopenia Cases in Older Adults: application of alternative cut-offs - Gülistan Bahat


NSS7
Crystals at the crossroad between inflammation and degeneration
Chairperson: Razvan Adrian Ionescu
Check your past, know your future - Claudiu Avram
Getting well or getting hell - Razvan Ionescu
The chicken or the egg: the causality dilemma - Mihai Bojinca
Look into the crystal bowl - Florentin Ananu Vreju


NSS8
Occupational musculoskeletal hazards among health professionals
Chairperson: Yesim Gökçe-Kutsal
Are health professionals vulnerable to work-related musculoskeletal disorders? - Yesim Gökçe-Kutsal
Neck and upper extremity disorders among health professionals - Yesim Kirazli
Occupational back and lower extremity problems in health personnel - Ayse A. Küçükdeveci


NSS9
Osteoporosis in 2020+: Flattening The Curve of Fragility Fractures
Chairperson: Bruno Muzzi Camargos
Introduction - Bruno Muzzi Camargos
Do You Believe in Tests ? - John Carey
To Mask or Not To Mask ? - Jorge Morales-Torres
How Awareness Could Change a Common Fate - Bruno Muzzi Camargos
Wrap-up/Discussion


NSS10
Latin America Audit 2021: Design and Implementation Impressions
Chairperson: Bruno Muzzi Camargos
What have changed on the osteoporosis care within the past ten years: from 2012 to 2021. - Adriana Medina
The two-phase approach - Phase 1 - Feasibility and Planning - Sonia Cerdas
The two-phase approach - Phase 2 - Data collection & Outputs - Claudia Campusano
Auditing one region: goals and challenges - Patricia Clark
Wrap-up (conclusion) of the initiative and what we have learned from doing such an effort covering this vast region which is Latin America.


NSS11
Fracture Liaison Services (FLS) in Latin America: From Where and Where To
Chairperson: Bruno Muzzi Camargos
Introduction - Overview of FLS in Latin America - Bruno Muzzi Camargos
Situation of the FLS in Mexico: barriers and strengths - Andrea Olascoaga Gómez de León
How fracture liaison services (FLS) impacted post-fracture outcomes in Colombia? - Adriana Medina Orjuela
FLS in public and private systems in Brazil: two worlds and a single outcome. - Bernardo Stolnick
Conclusion - Bruno Muzzi Camargos


NSS12
Osteoporosis in the context of autoimmune rheumatic diseases
Chairperson: Panagiotis Athanassiou
Autoimmune rheumatic diseases and osteoporosis - Panagiotis Athanassiou
Autoimmunity and osteoporosis - Ifigenia Kostoglou-Athanassiou
Biologic agents in autoimmune rheumatic diseases and bone health - Lambros Athanassiou
Management of osteoporosis in the context of autoimmune rheumatic diseases - Yannis Dionyssiotis


NSS13
Presentation of the book “Osteoporois: mitos y realidades“ (“Osteoporosis: myths and realities“)
Chairperson: David Vasquez-Awad
Opening - David Vasquez-Awad
"Osteoporosis: myths and realities" – the book - Jorge Felipe Ramirez
Osteoporosis: an economic perspective - Diego Rosseli
Osteoporosis, epidemic of the 21st century - David Vasquez-Awad
Conclusions and closure - Jorge Felipe Ramirez, Diego Rosseli, David Vasquez-Awad


NSS14
The State of the Art in Hypophosphatasia (HPP) Diagnosis in Adults and Children
Chairperson: Serge Ferrari
Current State in Diagnosis of HPP - Aliya Khan
Diagnostic Criteria for Children and Adolescents with - Eric Rush
Diagnostic Criteria for Adults with HPP - Maria Luisa Brandi


NSS15
Improving the Communication of Fracture risk
Chairperson: Mickael Hiligsmann
Welcome and introduction - Stuart Silverman
What can we learn from the literature? - Charlotte Beaudart
Insights from interviews with patients at risk for fractures (the RICO study) - Mickael Hiligsmann
- Key points, next steps & conclusion - Stuart Silverman


NSS16
Exercise to prevent deconditioning of older people during the covid-19 pandemic: from clinic to community setting
Chairperson: Mylène Aubertin-Leheudre
Feasibility of implementing physical activity programs in hospitalized positive covid-19 older adults - Yves Rolland
Remote Physical Activity using Web Technology to Prevent Isolation-Related Mobility Loss in Independent older adults: a solution during the COVID-19 pandemic? - Mylène Aubertin-Leheudre
Impacts of COVID-19 restrictions on functional status and mobility among community-dwelling pre-disabled seniors: Virtual Physical Exercises at Home, a solution? - Fanny Buckinx


NSS17
Osteosarcopenia in disabled persons
Chairperson: Christina-Anastasia Rapidi
Osteosarcopenia and neurodisability - Yannis Dionyssiotis
Physical activity in osteoporosis and sarcopenia management and rehabilitation - Mark A. Lissens
Conclusion - Discussion - All


NSS18
Rapid risk assessment and cost-effective methods for Osteoporosis in low resource settings – implication for practice
Chairperson: Fatjona Kamberi
Rapid risk assessment of osteoporosis using cost-effective methods – evidence from a cross sectional study in a South Eastern European country - Fatjona Kamberi
Health beliefs, knowledge and barriers of women in local population regarding Osteoporosis – A cross-sectional study - Enkeleda Sinaj
Awareness for early detection of Osteoporosis what the research in low resource settings suggests – evidence from a review study - Vjollca Ndreu
The role of vitamin D in patients with osteoporosis-review - Jerina Jaho


NSS19
Depression, antidepressive treatment and osteoporosis
Depression and osteoporosis - Ifigenia Kostoglou-Athanassiou
Stress and osteoporosis - Panagiotis Athanassiou
Antidepressive agents and osteoporosis - Lambros Athanassiou
Management of osteoporosis in the context of depression - Yannis Dionyssiotis


NSS20
Interdisciplinary approach to chronic musculoskeletal pain
Chairperson: Olga Kurushina
Interdisciplinary approach to biomechanics in chronic musculoskeletal pain - Alexander Barulin
Psychosomatics and cognitive-behavioral therapy in the treatment of chronic musculoskeletal pain - Olga Kurushina
Kinesiotaping in the correction of myofascial pain - Bogdan Kalinchenko
Non-pharmacological treatment in chronic musculoskeletal pain - Anna Drushlyakova


NSS21
The importance of Mediterranean diet in muscoloskeletal diseases
Chairperson: Stefania Maggi
Mediterranean diet and sarcopenia - Elaine Dennison
Mediterranean diet, osteoporosis and fracture - René Rizzoli
Mediterranean diet in osteoarthritis and other inflammatory rheumatological diseases - Nicola Veronese


NSS22
The effects of vitamin K on bone; beyond coagulation
Chairperson: Bo Abrahamsen
The biology of the active forms of vitamin K. - Dominic Harrington
The effects of vitamin K on bone health - Geeta Hampson


NSS23
Management of glucocorticoid induced osteoporosis
Chairpersons: Osvaldo Daniel Messina, Luis F Vidal Neira
Epidemiology and Pathogenesis - I. E. M. Bultink
Clinical features and diagnosis - OD Messina
Therapeutic options: Candidates for receiving therapy - H Ratermann
Modern treatment - W Lems


NSS24
Osteoclast activity defining bone strength in health and disease
Chairpersons: Marise Lazaretti Castro, Francisco José de Paula
Switching the osteoclast behavior determines the bone remodeling - Sandra Yasuyo Fukada
Osteoclasts on: bone fragility in the primary hyperparathyroidism - Francisco Bandeira
Osteoclasts off: quality of bone and fracture risk in the hypoparathyroidism - João Lindolfo Cunha Borges
Closing: last considerations


NSS25
Assessing quality of life in sarcopenia: new insights from the SarQoL® questionnaire”
Chairperson: Olivier Bruyère
Welcome, introduction and presentation of the SarQoL® questionnaire - Jean-Yves Reginster
Lecture 1. Clinimetric properties of Patient Reported Outcome Measures (PROMS) – Which methods for which purpose?: - Anton Geerinck
Lecture 2. The SarQoL® questionnaire – Clinimetric properties and novel applications - Charlotte Beaudart
Lecture 3. The Short-Form SarQoL® questionnaire - Development and validation of a Short Form Measure - Anton Geerinck
Key points & Discussion - Olivier Bruyère